Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Oxford Biomedica Share News (OXB)
OXB Share
Price
OXB Share
News
OXB Share
Chat
OXB Share
Trades528
OXB
Live RNS
OXB Share
Charts
OXB Level 2
Console
OXB Live
Share Price
OXB Broker
Ratings
OXB Directors
Deals
OXB Financial
Diary
OXB
Fundamentals
OXB Short
Positions1
OXB
Media
OXB Company
Research
OXB Company
Timeline1
Oxford Biomedica Information
Share Price Information for Oxford Biomedica (OXB)
Share Price is delayed by 15 minutes
Get Live Data
600.00
-10.00 (-1.64%)
Bid:
598.00
Ask:
600.00
Spread:
2.00 (0.334%)
Market Cap:
£726.05m
Last checked at -
Last checked at 
Intraday Oxford Biomedica Share Chart
Oxford Biomedica News
19 Jun 2020
IN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments
IN BRIEF: Oxford Biomedica Raises GBP40 Million To Fund Investments
18 Jun 2020
Oxford Biomedica Seeks To Raise GBP40 Million Via Share Placing
Oxford Biomedica Seeks To Raise GBP40 Million Via Share Placing
8 Jun 2020
Oxford Biomedica Says Sanofi To Return Rights To Two Programmes
Oxford Biomedica Says Sanofi To Return Rights To Two Programmes
8 Jun 2020
UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine
UK TRADING UPDATE SUMMARY: Oxford Biomedica Works On Covid-19 Vaccine
8 Jun 2020
UPDATE 2-UK stocks end lower on concerns over corporate debt; AstraZeneca weighs
* AstraZeneca slips on report of potential merger with Gilead* Plus500 falls after big revenue hit from client trading wins* Oil & gas stocks gain a...
3 Jun 2020
TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC
TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC
1 Jun 2020
UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO
UK EXECUTIVE CHANGE SUMMARY: Rambler Metals & Minerals Picks New CEO
1 Jun 2020
UPDATE 2-AstraZeneca scores twin drug approvals alongside vaccine progress
* Lynparza gains CHMP nod for advanced pancreatic cancer* Brilinta approved by FDA to cut risk of first heart attack* Coronavirus vaccine partner Oxfo...
Follow the stocks
